UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005475
Receipt No. R000006495
Scientific Title Mapping of brain cholinergic and dopaminergic alternations in rapid eye movement (REM) sleep behavior disorder by PET
Date of disclosure of the study information 2011/04/21
Last modified on 2020/05/11 18:17:42

No. Disposal Last modified on Item of update
1 Insert 2011/04/21 10:54:16
2 Update 2012/10/05 15:32:14 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2012/11/21 10:10:13 Condition
4 Update 2012/11/21 10:11:21 Last name of lead principal investigator
Last name of lead principal investigator
5 Update 2014/04/23 15:03:18 Email
Last name of contact person
Last name of contact person
Email
6 Update 2016/01/22 10:16:24 Basic design
No. of arms
Interventions/Control_2
Interventions/Control_2
Interventions/Control_3
Interventions/Control_3
7 Update 2017/08/28 08:24:43 Recruitment status
8 Update 2019/05/08 16:51:30 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Email

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Division name
Zip code
Email
Organization
Organization
Division name
Division name
Email
Name of primary sponsor
Institute
Institute
Organization
Category of Funding Organization
Organization1
Email1
Organization
Organization
Address
Address
Tel
Email
Institutions
9 Update 2020/05/11 18:08:29 Number of participants that the trial has enrolled
10 Update 2020/05/11 18:11:32 Recruitment status
Date of IRB
Last follow-up date
11 Update 2020/05/11 18:17:42 URL releasing protocol
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.